Pretreatment SUV could aid head and neck cancer therapy

02/25/2010 | EurekAlert!

The maximum standardized uptake value measured from FDG PET images of primary tumor in head and neck squamous cell carcinoma patients prior to treatment is predictive of disease-specific survival, overall survival and disease-free survival, a study said. The study also linked pretreatment SUVmax for lymphodenopathy to distant metastasis. "The findings of this study show that we may use SUV before treatment to personalize treatment approaches for some head and neck cancer patients since SUV has been shown to be associated with treatment outcomes," the study's lead author said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC